Patents by Inventor Shaoyu XU
Shaoyu XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11899227Abstract: The present disclosure provides a solar reflecting film and a preparation method thereof. The solar reflecting film includes a substrate and a functional layer stacked on each other. The functional layer includes a first reflecting layer, a barrier layer, and a second reflecting layer stacked on the substrate in order. The barrier layer includes a first barrier layer and a second barrier layer stacked on the first barrier layer. The first barrier layer is metal fluoride, inorganic non-metallic oxide, metal oxide or a combination thereof. The second barrier layer is metal oxides, metal nitrides, semiconductor doped compounds or a combination thereof. And a material of the first barrier layer is at least partially different from that of the second barrier layer.Type: GrantFiled: April 10, 2020Date of Patent: February 13, 2024Assignees: NINGBO RADI-COOL ADVANCED ENERGY TECHNOLOGIES CO., LTD., NINGBO RUILING ADVANCED ENERGY MATERIALS INSTITUTE CO., LTD.Inventors: Ronggui Yang, Shaoyu Xu, Minghui Wang, Huailun Zhai, Yulei Yan, Zhengjie Yin, Jinling Zhao
-
Publication number: 20240019180Abstract: A radiative cooling film and a product thereof are provided. The radiative cooling film includes a carrier layer, a reflective layer and an emissive layer stacked together. A light shines on the radiative cooling film from the emissive layer. The emissive layer includes a polymer containing a C—F bond. The carrier layer includes a polymer containing at least one of a C—C bond and a C—O bond. After disposing at 120 degrees centigrade for 30 minutes, a transverse direction heat-shrinkage rate of the carrier layer is less than or equal to 2%, and a machine direction heat-shrinkage rate of the carrier layer is less than or equal to 3%. A thickness of the radiative cooling film is in a range of 50 ?m to 170 ?m, and a thickness of the emissive layer accounts for 20% to 90% of the thickness of the radiative cooling film.Type: ApplicationFiled: March 1, 2021Publication date: January 18, 2024Inventors: Shaoyu XU, Ronggui YANG, Song ZHONG, Minghui WANG, Zhengjie YIN, Huihui YANG, Zhaolu XIA
-
Patent number: 11867434Abstract: A radiative cooling film and a product thereof are provided. The radiative cooling film includes a carrier layer, a reflective layer and an emissive layer stacked together. A light shines on the radiative cooling film from the emissive layer. The emissive layer includes a polymer containing a C—F bond. The carrier layer includes a polymer containing at least one of a C—C bond and a C—O bond. After disposing at 120 degrees centigrade for 30 minutes, a transverse direction heat-shrinkage rate of the carrier layer is less than or equal to 2%, and a machine direction heat-shrinkage rate of the carrier layer is less than or equal to 3%. A thickness of the radiative cooling film is in a range of 50 m to 170 ?m, and a thickness of the emissive layer accounts for 20% to 90% of the thickness of the radiative cooling film.Type: GrantFiled: March 1, 2021Date of Patent: January 9, 2024Assignees: NINGBO RADI-COOL ADVANCED ENERGY TECHNOLOGIES CO., LTD., NINGBO RUILING ADVANCED ENERGY MATERIALS INSTITUTE CO., LTD.Inventors: Shaoyu Xu, Ronggui Yang, Song Zhong, Minghui Wang, Zhengjie Yin, Huihui Yang, Zhaolu Xia
-
Patent number: 11833780Abstract: The present disclosure provides a radiative cooling metal plate, a preparation method and application thereof. The radiative cooling metal plate includes a metal substrate, a first adhesive layer and a radiative cooling functional layer stacked in order, the radiative cooling functional layer is located on a surface of the metal substrate, the first adhesive layer is arranged between the metal substrate and the radiative cooling functional layer, and an elongation at break of the radiative cooling functional layer is in a range of 1% to 300%. The radiative cooling functional layer can have sufficient ductility, and can have sufficient deformation to cope with the bending of the radiative cooling functional layer during pressing, such that the radiative cooling functional layer will not be damaged or broken, thereby ensuring the structural integrity of the radiative cooling functional layer and great radiative cooling effect of the metal substrate.Type: GrantFiled: April 29, 2020Date of Patent: December 5, 2023Assignees: NINGBO RADI-COOL ADVANCED ENERGY TECHNOLOGIES CO., LTD., NINGBO RUILING ADVANCED ENERGY MATERIALS INSTITUTE CO., LTD.Inventors: Ronggui Yang, Shaoyu Xu, Zhixiong Chen, Minghui Wang, Huihui Yang, Zhaolu Xia, Peng Cao
-
Patent number: 11780923Abstract: The present invention relates to a PD-L1 antibody, antigen-binding fragments, and medical application thereof. Further, the present invention relates to chimeric antibodies and humanized antibodies comprising the CDR regions of the present PD-L1 antibody, as well as a pharmaceutical composition comprising the present PD-L1 antibody and the antigen-binding fragments thereof, and their use as anti-cancer drugs. In particular, the present invention relates to a humanized PD-L1 antibody and its use in preparation of a medicament for the treatment of PD-L1 mediated disease or disorder.Type: GrantFiled: August 7, 2020Date of Patent: October 10, 2023Assignees: Suzhou Suncadia Biopharmaceuticals Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.Inventors: Xiangdong Qu, Qiyue Hu, Shaoyu Xu, Dongbing Cui, Houcong Jin, Weikang Tao, Lianshan Zhang, Guoqing Cao, Piaoyang Sun
-
Publication number: 20230161085Abstract: The present disclosure provides a solar reflecting film and a preparation method thereof. The solar reflecting film includes a substrate and a functional layer stacked on each other. The functional layer includes a first reflecting layer, a barrier layer, and a second reflecting layer stacked on the substrate in order. The barrier layer includes a first barrier layer and a second barrier layer stacked on the first barrier layer. The first barrier layer is metal fluoride, inorganic non-metallic oxide, metal oxide or a combination thereof. The second barrier layer is metal oxides, metal nitrides, semiconductor doped compounds or a combination thereof. And a material of the first barrier layer is at least partially different from that of the second barrier layer.Type: ApplicationFiled: April 10, 2020Publication date: May 25, 2023Inventors: Ronggui YANG, Shaoyu XU, Minghui WANG, Huailun ZHAI, Yulei YAN, Zhengjie YIN, Jinling ZHAO
-
Publication number: 20230150242Abstract: The present disclosure provides a radiative cooling metal plate, a preparation method and application thereof. The radiative cooling metal plate includes a metal substrate, a first adhesive layer and a radiative cooling functional layer stacked in order, the radiative cooling functional layer is located on a surface of the metal substrate, the first adhesive layer is arranged between the metal substrate and the radiative cooling functional layer, and an elongation at break of the radiative cooling functional layer is in a range of 1% to 300%. The radiative cooling functional layer can have sufficient ductility, and can have sufficient deformation to cope with the bending of the radiative cooling functional layer during pressing, such that the radiative cooling functional layer will not be damaged or broken, thereby ensuring the structural integrity of the radiative cooling functional layer and great radiative cooling effect of the metal substrate.Type: ApplicationFiled: April 29, 2020Publication date: May 18, 2023Inventors: Ronggui YANG, Shaoyu XU, Zhixiong CHEN, Minghui WANG, Huihui YANG, Zhaolu XIA, Peng CAO
-
Patent number: 10947394Abstract: The present disclosure provides a radiative cooling functional coating material and application thereof. The radiative cooling functional coating material can be configured for manufacturing a radiative cooling functional layer. The radiative cooling functional layer can be configured for reflecting ultraviolet light and/or visible light and/or near-infrared light in sunlight and emitting heat through an atmospheric window in a form of infrared radiation. The radiative cooling functional coating material can include a granular filler and a radiative cooling functional resin, and the granular filler can be distributed in the radiative cooling functional resin.Type: GrantFiled: September 18, 2019Date of Patent: March 16, 2021Assignees: NINGBO RADI-COOL ADVANCED ENERGY TECHNOLOGIES CO., LTD., NINGBO RUILING ADVANCED ENERGY MATERIALS INSTITUTE CO., LTD.Inventors: Shaoyu Xu, Rongbing Wan, Minghui Wang
-
Publication number: 20210002491Abstract: The present disclosure provides a radiative cooling functional coating material and application thereof. The radiative cooling functional coating material can be configured for manufacturing a radiative cooling functional layer. The radiative cooling functional layer can be configured for reflecting ultraviolet light and/or visible light and/or near-infrared light in sunlight and emitting heat through an atmospheric window in a form of infrared radiation. The radiative cooling functional coating material can include a granular filler and a radiative cooling functional resin, and the granular filler can be distributed in the radiative cooling functional resin.Type: ApplicationFiled: September 18, 2019Publication date: January 7, 2021Inventors: Shaoyu XU, Rongbing WAN, Minghui WANG
-
Publication number: 20200399375Abstract: The present invention relates to a PD-L1 antibody, antigen-binding fragments, and medical application thereof. Further, the present invention relates to chimeric antibodies and humanized antibodies comprising the CDR regions of the present PD-L1 antibody, as well as a pharmaceutical composition comprising the present PD-L1 antibody and the antigen-binding fragments thereof, and their use as anti-cancer drugs. In particular, the present invention relates to a humanized PD-L1 antibody and its use in preparation of a medicament for the treatment of PD-L1 mediated disease or disorder.Type: ApplicationFiled: August 7, 2020Publication date: December 24, 2020Inventors: Xiangdong Qu, Qiyue Hu, Shaoyu Xu, Dongbing Cui, Houcong Jin, Weikang Tao, Lianshan Zhang, Guoqing Cao, Piaoyang Sun
-
Patent number: 10815304Abstract: The present invention relates to a PD-L1 antibody, antigen-binding fragments, and medical application thereof. Further, the present invention relates to chimeric antibodies and humanized antibodies comprising the CDR regions of the present PD-L1 antibody, as well as a pharmaceutical composition comprising the present PD-L1 antibody and the antigen-binding fragments thereof, and their use as anti-cancer drugs. In particular, the present invention relates to a humanized PD-L1 antibody and its use in preparation of a medicament for the treatment of PD-L1 mediated disease or disorder.Type: GrantFiled: November 2, 2016Date of Patent: October 27, 2020Assignees: Suzhou Suncadia Biopharmaceuticals Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.Inventors: Xiangdong Qu, Qiyue Hu, Shaoyu Xu, Dongbing Cui, Houcong Jin, Weikang Tao, Lianshan Zhang, Guoqing Cao, Piaoyang Sun
-
Patent number: 10793643Abstract: The present invention provides a PCSK9 antibody, an antigen-binding fragment thereof, and a medicinal application thereof. Provided in the invention is a chimeric antibody and a humanized antibody, both comprising a CDR of the PCSK9 antibody, and a pharmaceutical composition comprising the PCSK9 antibody and an antigen-binding fragment thereof, and an application of the PCSK9 antibody as a lipid-lowering agent. The invention specifically relates to an application of a humanized PCSK9 antibody for preparing a pharmaceutical drug to treat a PCSK9-induced disease or symptom.Type: GrantFiled: December 20, 2016Date of Patent: October 6, 2020Assignees: Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.Inventors: Xiangdong Qu, Xin Ye, Shaoyu Xu, Bei Yuan, Dongbing Cui, Qiyue Hu, Lei Zhang, Zhibin Xu, Weikang Tao, Lianshan Zhang, Piaoyang Sun
-
Publication number: 20190016825Abstract: The present invention provides a PCSK9 antibody, an antigen-binding fragment thereof, and a medicinal application thereof. Provided in the invention is a chimeric antibody and a humanized antibody, both comprising a CDR of the PCSK9 antibody, and a pharmaceutical composition comprising the PCSK9 antibody and an antigen-binding fragment thereof, and an application of the PCSK9 antibody as a lipid-lowering agent. The invention specifically relates to an application of a humanized PCSK9 antibody for preparing a pharmaceutical drug to treat a PCSK9-induced disease or symptom.Type: ApplicationFiled: December 20, 2016Publication date: January 17, 2019Inventors: Xiangdong QU, Xin YE, Shaoyu XU, Bei YUAN, Dongbing CUI, Qiyue HU, Lei ZHANG, Zhibin XU, Weikang TAO, Lianshan ZHANG, Piaoyang SUN
-
Publication number: 20180334504Abstract: The present invention relates to a PD-L1 antibody, antigen-binding fragments, and medical application thereof. Further, the present invention relates to chimeric antibodies and humanized antibodies comprising the CDR regions of the present PD-L1 antibody, as well as a pharmaceutical composition comprising the present PD-L1 antibody and the antigen-binding fragments thereof, and their use as anti-cancer drugs. In particular, the present invention relates to a humanized PD-L1 antibody and its use in preparation of a medicament for the treatment of PD-L1 mediated disease or disorder.Type: ApplicationFiled: November 2, 2016Publication date: November 22, 2018Applicants: Suzhou Suncadia Biopharmaceuticals Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd.Inventors: Xiangdong QU, Qiyue HU, Shaoyu XU, Dongbing CUI, Houcong JIN, Weikang TAO, Lianshan ZHANG, Guoqing CAO, Piaoyang SUN